CCL2 can enhance the migration and invasion ability of prostate cancer cells (Natsagdorj and Izumi, 2019), as well as induce the invasion of liver cancer cells (Zhuang et al., 2018). The gene discussed is CCL2; the disease is Familial prostate cancer.